|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,015.00 GBX | +0.55% |
|
+1.61% | +10.44% |
| 07-03 | FTSE 100 up as US jobs data eases rate hike fears | AN |
| 07-02 | London's FTSE 100 inches lower as Middle East concerns weigh | RE |
| Market Cap | 80.29B 107B 93.68B 86.15B 152B 10,203B 155B 1,033B 402B 5,017B 402B 394B 17,303B | P/E 2026 * |
13x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 95.27B 127B 111B 102B 181B 12,107B 183B 1,225B 477B 5,953B 477B 467B 20,532B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.59x |
| Free-Float |
92.29% | Yield 2026 * |
3.47% | Yield 2027 * | 3.64% |
Last Transcript: GSK plc
| 1 day | +0.55% | ||
| 1 week | +1.61% | ||
| Current month | +1.72% | ||
| 1 month | +5.94% | ||
| 3 months | -6.02% | ||
| 6 months | +10.02% | ||
| Current year | +10.44% |
| 1 week | 1,930 |  | 2,015 |
| 1 month | 1,839 | | 2,015 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +1.61% | +43.42% | +46.12% | 107B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| -0.26% | +1.37% | +31.00% | +23.97% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.53% | +4.17% | +32.20% | +56.62% | 379.96B | |
| Weighted average by Cap. | +1.83% | +5.32% | +41.80% | +81.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.19B 39.51B 36.33B 64.19B 4,303B 65.16B 435B 169B 2,116B 170B 166B 7,297B | 35.56B 47.46B 41.49B 38.15B 67.41B 4,519B 68.43B 457B 178B 2,222B 178B 174B 7,663B |
| Net income | 6.47B 8.64B 7.55B 6.94B 12.27B 822B 12.45B 83.22B 32.39B 404B 32.41B 31.72B 1,395B | 6.94B 9.26B 8.09B 7.44B 13.15B 881B 13.35B 89.19B 34.71B 433B 34.73B 34B 1,495B |
| Net Debt | 14.98B 20B 17.48B 16.08B 28.4B 1,904B 28.83B 193B 74.98B 936B 75.03B 73.44B 3,229B | 11.74B 15.66B 13.69B 12.59B 22.25B 1,491B 22.58B 151B 58.74B 733B 58.78B 57.53B 2,529B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
| 02/07/26 | GBX 2,004.00 | +3.83% | 17,567,408 |
| 01/07/26 | GBX 1,930.00 | -2.57% | 8,818,924 |
| 30/06/26 | GBX 1,981.00 | +0.08% | 13,958,407 |
| 29/06/26 | GBX 1,979.50 | -0.18% | 9,719,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
